UK markets closed
NIKKEI 225
27,419.61 -47.00 (-0.17%) HANG SENG
20,049.64 +458.21 (+2.34%) CRUDE OIL
69.51 -0.45 (-0.64%) GOLD FUTURES
1,995.40 -0.50 (-0.03%) DOW
32,105.25 +75.14 (+0.23%) Bitcoin GBP
23,122.29 +842.78 (+3.78%)
Citius Pharmaceuticals, Inc. (CTXR)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.9901 |
| Open | 1.0000 |
| Bid | 0.9901 x 1800 |
| Ask | 0.9998 x 1200 |
| Day's range | 0.9900 - 1.0400 |
| 52-week range | 0.7700 - 2.0100 |
| Volume | |
| Avg. volume | 890,815 |
| Market cap | 147.159M |
| Beta (5Y monthly) | 1.40 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1800 |
| Earnings date | 10 May 2023 - 15 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.00 |
- Simply Wall St.
Here's Why We're Not Too Worried About Citius Pharmaceuticals' (NASDAQ:CTXR) Cash Burn Situation
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
- Zacks
After Plunging -30.6% in 4 Weeks, Here's Why the Trend Might Reverse for Citius Pharmaceuticals, Inc. (CTXR)
The heavy selling pressure might have exhausted for Citius Pharmaceuticals, Inc. (CTXR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- Simply Wall St.
Citius Pharmaceuticals, Inc.'s (NASDAQ:CTXR) Profit Outlook
With the business potentially at an important milestone, we thought we'd take a closer look at Citius Pharmaceuticals...
© 2023 Yahoo. All rights reserved.
